Cool, now the indexing?
https://www.paho.org/english/sha/be_v23n3-standardization.htmCool, now the indexing?
Cool, now the indexing?
https://www.paho.org/english/sha/be_v23n3-standardization.htmCool, now the indexing?
Okay. I just remember the back and forth.
It has been proven to be more than just that. It’s disingenuous to say otherwise.But at the time hydroxy was a life-saver for people with Lupus, and a run on the drug for misguided political purposes would have put them at risk.
It has been proven to be more than just that. It’s disingenuous to say otherwise.
Agreed. It works as a prevention and treatment of malaria.It has been proven to be more than just that. It’s disingenuous to say otherwise.
Evidence from RCTs suggests that AZ with or without HCQ was not associated with a significant effect on the mortality or mechanical ventilation rates in hospitalized patients with COVID-19. More research is needed to explore therapeutics agents that can effectively reduce the mortality or severity of COVID-19.
Current evidence does not support using either of these agents alone or in combination in the management of hospitalized patients with COVID-19 infection.
I don’t think Guy would consider himself Liberal based on what he stated in his past :dunno
Mayo disagrees with your clinical assessment.Agreed. It works as a prevention and treatment of malaria.
Covid? Not so much.
https://onlinelibrary.wiley.com/doi/10.1002/jmv.27259
So does Henry Ford and othersArchy1221 said:I don’t think Guy would consider himself Liberal based on what he stated in his past :dunno
Mayo disagrees with your clinical assessment.
It has been proven to be more than just that. It’s disingenuous to say otherwise.
I don’t think Guy would consider himself Liberal based on what he stated in his past :dunno
Oh they do?Mayo disagrees with your clinical assessment.
Moderate certainty evidence suggests that HCQ, with or without azithromycin, lacks efficacy in reducing short-term mortality in patients hospitalized with COVID-19 or risk of hospitalization in outpatients with COVID-19.
Oh they do?So does Henry Ford and others
Henry Ford Health System officials told Bridge Michigan they could not find enough participants to continue studying whether the drug could help beat back the deadly pandemic.
Hydroxychloroquine — an antimalarial drug that has also proven useful in treating rheumatoid arthritis, lupus and other inflammatory diseases — briefly produced some excitement last spring when it was promoted as a potential game-changer by President Trump. But early optimism gave way to broader medical studies, with the nation’s top health agencies eventually determining it was not effective in treating or preventing the spread of the novel coronavirus.
The Henry Ford study (WHIP COVID-19 clinical trial), was to involve 3,000 health care workers, first responders, public transit drivers, or family members of health workers to determine whether hydroxychloroquine would prevent COVID-19 on the frontlines.
“We know that it’s going to be very popular, and we will try to enroll as many people as we can,” Henry Ford cardiologist William W. O’Neill said at the time of the study’s announcement, held with Detroit Mayor Mike Duggan.
But that optimism proved misplaced, with just 624 people signing up. Henry Ford quietly ended the study just before Christmas.
“The updated randomized evidence provides even stronger support for the halt on prescribing hydroxychloroquine in the prevention or treatment of COVID-19,” said Charles H. Hennekens, M.D., Dr.PH, senior author, the first Sir Richard Doll professor and senior academic advisor in FAU’s Schmidt College of Medicine.
The authors say that in addition to a lack of significant benefit, the new randomized evidence shows some suggestion of harm. They explain that the prior reassuring safety profile of hydroxychloroquine is applicable to patients with lupus and rheumatoid arthritis, both of which are of greater prevalence in younger and middle-age women, whose risks of fatal heart outcomes due to hydroxychloroquine are reassuringly very low.
In contrast, the risks of hydroxychloroquine for patients with COVID-19 are significantly higher because fatal cardiovascular complications due to these drugs are so much higher in older patients and those with existing heart disease or its risk factors, both of whom are more predominant in men
Would you like to dispute the data like an adult or just whine about where it came from like a child?
I doubled up on the Viagra for two weeks after I tested positive. Wife wouldn't leave me alone the whole time. Feel great now but anyone would have rather been on the ventilator if they got a look at the wifey.anyone have any ideas?
What did the findings show? You left that out